Juniper Biologics Pte. Ltd.

Science-led biopharmaceutical company founded in 2020, with global headquarters in Singapore. Specialized in development and commercialization of novel therapies for unmet medical needs: oncology and oncology supportive care, gene therapy, and rare/orphan diseases. Backed by The Sylvan Group (private equity). "Most Innovative Oncology Pharmaceutical Company 2023" award (GHP Awards).